Amarantus Bioscience Holdings (OTCMKTS:AMBS) Reaches Non-Binding Term Sheet to Divest Cutanogen Corporation
JLABS-alumnus biotechnology holding company developing orphan neurologic, regenerative medicine and ophthalmic therapies, Amarantus Bioscience Holdings (OTCMKTS:AMBS), on April 27, 2022, released letter to the shareholders announcing foray into non-binding term sheet for selling its Engineered Skin Substitute subsidiary, Cutanogen Corporation.… Continue Reading